Systemic adversities of ovarian failure

Area of Science:

• Reproductive Endocrinology
• Gynecology

Background:

• Normal ovarian function is intricate, involving multiple hormones and cell types.
• Ovarian failure results in the deficiency of estrogenic steroids, progestins, androgens, protein hormones, growth factors, and oocytes.
• The process of ovarian failure can be intermittent, complicating diagnosis and treatment.

Purpose of the Study:

• To elucidate the multifaceted systemic consequences of ovarian failure.
• To highlight the poorly understood effects of losing various ovarian products beyond estrogen.
• To emphasize the diagnostic and therapeutic challenges posed by intermittent ovarian failure.

Main Methods:

• Review of existing literature on ovarian physiology and failure.
• Analysis of the systemic impacts based on the timing and affected ovarian compartments.
• Synthesis of information regarding the physiological implications of losing diverse ovarian products.

Main Results:

• Ovarian failure leads to deficiencies in a wide array of hormones and cellular components, not solely estrogen.
• The systemic impact varies significantly depending on the timing of failure (pre-pubertal, reproductive age, post-menopausal) and specific ovarian functions lost.
• The loss of progestins, androgens, and other ovarian products contributes to systemic effects that are not well-characterized.

Conclusions:

• Cessation of ovarian function has broad physiological implications extending beyond estrogen deficiency.
• Premature ovarian failure, caused by underlying diseases, may present with additional systemic symptoms.
• A comprehensive understanding of all ovarian product losses is essential for managing women with ovarian failure.